Who is sponsoring NCT04163770?

NCT04163770 is sponsored by Assiut University.

What drugs are being tested in NCT04163770?

Interventions in NCT04163770: caliberation of pacemaker, caliberation of pacemaker.

What condition does NCT04163770 study?

NCT04163770 studies Disorder of Cardiac Pacemaker System.

Is NCT04163770 still recruiting?

NCT04163770 is currently status unknown. Last updated 15 November 2019.

Last reviewed 2019-11-15 · How we verify

NCT04163770

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation Of Pacemakers in Children

Status unknown NA Last updated 15 November 2019

What this trial tests

NA trial testing caliberation of pacemaker in Disorder of Cardiac Pacemaker System in 40 participants. Status unknown.

Timeline

15 January 2020

Primary endpoint
15 January 2021

15 February 2021

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	40
Start date	15 January 2020
Primary completion	15 January 2021
Estimated completion	15 February 2021

Drugs / interventions tested

caliberation of pacemaker
caliberation of pacemaker

Conditions studied

Disorder of Cardiac Pacemaker System — all drugs for Disorder of Cardiac Pacemaker System →

Sponsor

Assiut University

Who can join

Under 18, any sex, with Disorder of Cardiac Pacemaker System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pacemakers were introduced into clinical practice several decades ago and currently are used in a growing number of patients. Since insertion of the first cardiac Pacemaker in 1958, vast changes have occurred in both the technology of the devices and their indications. Devices have evolved from single-lead and fixed-rate systems to multi chamber rate-responsive systems with increasingly sophisticated software . Pediatric Pacemaker implants comprise less than 1 % of all implants. The indications for pacing in newborns and infants are divided predominantly into three groups: congenital abnormalities of the conduction system, acquired heart blocks after cardiac surgery for correction of congenital defects, and sinus node diseases

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04163770 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 15 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing